Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00930904 · ClinicalTrials.gov registry record
Model 4196 Left Ventricular (LV) Lead Chronic Performance Study
A clinical trial, sponsored by Medtronic.
- Completed
- Registry status
- 1,847
- Enrollment target
NCT00930904: Completed study, sponsored by Medtronic.
NCT00930904 is a clinical trial that has completed, run by Medtronic. The registered enrollment target is 1,847 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00930904 has completed, sponsored by Medtronic.
- COMPLETED
- Registry status
- 1,847 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate long-term performance of the 4196 LV Lead. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study is required by FDA as a condition of approval of the Model 4196 LV Lead and is integrated within the Product Surveillance Registry (PAN Registry).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,847 participants |
| Start Date | 2009-06 |
| Est. Completion | 2017-04 |
What the finished NCT00930904 record still lists
NCT00930904 is an observational study that tracks outcomes without assigning an intervention. Its 1,847 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00930904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00930904 about?
NCT00930904 is a clinical study titled "Model 4196 Left Ventricular (LV) Lead Chronic Performance Study". The purpose of this study is to evaluate long-term performance of the 4196 LV Lead. This evaluation is based on the number of lead-related complications occurring during the study compared to the number of leads enrolled in the study. The leads will be followed for 5 years after implant. This study ...
What is the current status of trial NCT00930904?
This trial is currently completed. The enrollment target is 1,847 participants. The study started on 2009-06. Estimated completion is 2017-04.
Who is sponsoring clinical trial NCT00930904?
This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06465810 · 1,850 participants
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- NCT06580080 · 1,850 participants · NA
Evaluation of Are You Ready?
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia